ABVX PE Ratio & Valuation, Is ABVX Overvalued

Historical Valuation

Abivax SA (ABVX) is now in the Fair zone, suggesting that its current forward PS ratio of 295.08 is considered Fairly compared with the five-year average of -8.25. The fair price of Abivax SA (ABVX) is between 8.60 to 127.69 according to relative valuation method.

Relative Value

Fair Zone

8.60-127.69

Current Price：115.28

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Abivax SA (ABVX) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Abivax SA (ABVX) has a current Price-to-Book (P/B) ratio of 17.51. Compared to its 3-year average P/B ratio of -14.59, the current P/B ratio is approximately -220.01% higher. Relative to its 5-year average P/B ratio of -0.75, the current P/B ratio is about -2443.70% higher. Abivax SA (ABVX) has a Forward Free Cash Flow (FCF) yield of approximately -1.92%. Compared to its 3-year average FCF yield of -18.23%, the current FCF yield is approximately -89.48% lower. Relative to its 5-year average FCF yield of -16.58%, the current FCF yield is about -88.44% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for ABVX competitors is 50.43, providing a benchmark for relative valuation. Abivax SA Corp (ABVX.O) exhibits a P/S ratio of 295.08, which is 485.09% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of ABVX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of ABVX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is ABVX currently overvalued or undervalued?

What is Abivax SA (ABVX) fair value?

ABVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Abivax SA (ABVX) is between 8.60 to 127.69 according to relative valuation method.

How does ABVX's valuation metrics compare to the industry average?

The average P/S ratio for ABVX's competitors is 50.43, providing a benchmark for relative valuation. Abivax SA Corp (ABVX) exhibits a P/S ratio of 295.08, which is 485.09% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Abivax SA (ABVX) as of Mar 11 2026?

As of Mar 11 2026, Abivax SA (ABVX) has a P/B ratio of 17.51. This indicates that the market values ABVX at 17.51 times its book value.

What is the current FCF Yield for Abivax SA (ABVX) as of Mar 11 2026?

As of Mar 11 2026, Abivax SA (ABVX) has a FCF Yield of -1.92%. This means that for every dollar of Abivax SA's market capitalization, the company generates -1.92 cents in free cash flow.

What is the current Forward P/E ratio for Abivax SA (ABVX) as of Mar 11 2026?

As of Mar 11 2026, Abivax SA (ABVX) has a Forward P/E ratio of -41.67. This means the market is willing to pay $-41.67 for every dollar of Abivax SA's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Abivax SA (ABVX) as of Mar 11 2026?

As of Mar 11 2026, Abivax SA (ABVX) has a Forward P/S ratio of 295.08. This means the market is valuing ABVX at $295.08 for every dollar of expected revenue over the next 12 months.

ABVX Valuation